Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

1.

Discovery and confirmation of a protein biomarker panel with potential to predict response to biological therapy in psoriatic arthritis.

Ademowo OS, Hernandez B, Collins E, Rooney C, Fearon U, van Kuijk AW, Tak PP, Gerlag DM, FitzGerald O, Pennington SR.

Ann Rheum Dis. 2014 Sep 3. pii: annrheumdis-2014-205417. doi: 10.1136/annrheumdis-2014-205417. [Epub ahead of print]

PMID:
25187158
[PubMed - as supplied by publisher]
2.

From synovial tissue to peripheral blood: myeloid related protein 8/14 is a sensitive biomarker for effective treatment in early drug development in patients with rheumatoid arthritis.

Choi IY, Gerlag DM, Holzinger D, Roth J, Tak PP.

PLoS One. 2014 Aug 28;9(8):e106253. doi: 10.1371/journal.pone.0106253. eCollection 2014.

PMID:
25166859
[PubMed - in process]
Free PMC Article
3.

Heterogeneous expression pattern of interleukin-17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for non-response to anti-IL-17 therapy?

van Baarsen L, Lebre M, van der Coelen D, Aarrass S, Tang M, Ramwadhdoebe TH, Gerlag DM, Tak PP.

Arthritis Res Ther. 2014 Aug 22;16(5):426. [Epub ahead of print]

PMID:
25146432
[PubMed - as supplied by publisher]
4.

Clock gene expression in different synovial cells of patients with rheumatoid arthritis and osteoarthritis.

Becker T, Tohidast-Akrad M, Humpeler S, Gerlag DM, Kiener HP, Zenz P, Steiner G, Ekmekcioglu C.

Acta Histochem. 2014 Sep;116(7):1199-207. doi: 10.1016/j.acthis.2014.07.001. Epub 2014 Aug 7.

PMID:
25109449
[PubMed - in process]
5.

Citrullination of ENA-78/CXCL5 results in conversion from a non-monocyte recruiting to a monocyte recruiting chemokine.

Yoshida K, Korchynskyi O, Tak PP, Isozaki T, Ruth JH, Campbell PL, Baeten DL, Gerlag DM, Amin MA, Koch AE.

Arthritis Rheumatol. 2014 Jun 18. doi: 10.1002/art.38750. [Epub ahead of print]

PMID:
24943990
[PubMed - as supplied by publisher]
6.

Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis.

Greven DE, Cohen ES, Gerlag DM, Campbell J, Woods J, Davis N, van Nieuwenhuijze A, Lewis A, Heasmen S, McCourt M, Corkill D, Dodd A, Elvin J, Statache G, Wicks IP, Anderson IK, Nash A, Sleeman MA, Tak PP.

Ann Rheum Dis. 2014 Jun 16. pii: annrheumdis-2014-205234. doi: 10.1136/annrheumdis-2014-205234. [Epub ahead of print]

PMID:
24936585
[PubMed - as supplied by publisher]
Free Article
7.

Reply: To PMID 24574210.

de Hair MJ, van de Sande MG, Ramwadhdoebe TH, van der Leij C, Maas M, Hansson M, Klareskog L, Landewé R, Serre G, van Schaardenburg D, Gerlag DM, van Baarsen LG, Tak PP.

Arthritis Rheumatol. 2014 Jun;66(6):1683-4. doi: 10.1002/art.38411. No abstract available.

PMID:
24577836
[PubMed - indexed for MEDLINE]
8.

Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis.

de Hair MJ, van de Sande MG, Ramwadhdoebe TH, Hansson M, Landewé R, van der Leij C, Maas M, Serre G, van Schaardenburg D, Klareskog L, Gerlag DM, van Baarsen LG, Tak PP.

Arthritis Rheumatol. 2014 Mar;66(3):513-22. doi: 10.1002/art.38273.

PMID:
24574210
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

FMS-related tyrosine kinase 3 ligand (Flt3L)/CD135 axis in rheumatoid arthritis.

Ramos MI, Perez SG, Aarrass S, Helder B, Broekstra P, Gerlag DM, Reedquist KA, Tak PP, Lebre MC.

Arthritis Res Ther. 2013;15(6):R209.

PMID:
24314260
[PubMed - in process]
Free PMC Article
10.

MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis.

Choi IY, Gerlag DM, Herenius MJ, Thurlings RM, Wijbrandts CA, Foell D, Vogl T, Roth J, Tak PP, Holzinger D.

Ann Rheum Dis. 2013 Dec 2. doi: 10.1136/annrheumdis-2013-203923. [Epub ahead of print]

PMID:
24297376
[PubMed - as supplied by publisher]
11.

Local synovial engagement of angiogenic TIE-2 is associated with the development of persistent erosive rheumatoid arthritis in patients with early arthritis.

van de Sande MG, de Launay D, de Hair MJ, García S, van de Sande GP, Wijbrandts CA, Gerlag DM, Reedquist KA, Tak PP.

Arthritis Rheum. 2013 Dec;65(12):3073-83. doi: 10.1002/art.38128.

PMID:
23982963
[PubMed - indexed for MEDLINE]
12.

Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis.

Strang AC, Bisoendial RJ, Kootte RS, Schulte DM, Dallinga-Thie GM, Levels JH, Kok M, Vos K, Tas SW, Tietge UJ, Müller N, Laudes M, Gerlag DM, Stroes ES, Tak PP.

Atherosclerosis. 2013 Jul;229(1):174-81. doi: 10.1016/j.atherosclerosis.2013.04.031. Epub 2013 May 11.

PMID:
23746537
[PubMed - indexed for MEDLINE]
13.

How to perform and analyse synovial biopsies.

Gerlag DM, Tak PP.

Best Pract Res Clin Rheumatol. 2013 Apr;27(2):195-207. doi: 10.1016/j.berh.2013.03.006. Review.

PMID:
23731931
[PubMed - indexed for MEDLINE]
14.

The cellular composition of lymph nodes in the earliest phase of inflammatory arthritis.

van Baarsen LG, de Hair MJ, Ramwadhdoebe TH, Zijlstra IJ, Maas M, Gerlag DM, Tak PP.

Ann Rheum Dis. 2013 Aug;72(8):1420-4. doi: 10.1136/annrheumdis-2012-202990. Epub 2013 May 9.

PMID:
23661491
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Rheumatoid arthritis synovial tissue harbours dominant B-cell and plasma-cell clones associated with autoreactivity.

Doorenspleet ME, Klarenbeek PL, de Hair MJ, van Schaik BD, Esveldt RE, van Kampen AH, Gerlag DM, Musters A, Baas F, Tak PP, de Vries N.

Ann Rheum Dis. 2014 Apr;73(4):756-62. doi: 10.1136/annrheumdis-2012-202861. Epub 2013 Apr 20.

PMID:
23606709
[PubMed - indexed for MEDLINE]
16.

Anti-TNF therapy reduces serum levels of chemerin in rheumatoid arthritis: a new mechanism by which anti-TNF might reduce inflammation.

Herenius MM, Oliveira AS, Wijbrandts CA, Gerlag DM, Tak PP, Lebre MC.

PLoS One. 2013;8(2):e57802. doi: 10.1371/journal.pone.0057802. Epub 2013 Feb 27.

PMID:
23460910
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Smoking and overweight determine the likelihood of developing rheumatoid arthritis.

de Hair MJ, Landewé RB, van de Sande MG, van Schaardenburg D, van Baarsen LG, Gerlag DM, Tak PP.

Ann Rheum Dis. 2013 Oct;72(10):1654-8. doi: 10.1136/annrheumdis-2012-202254. Epub 2012 Oct 27.

PMID:
23104761
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Streptococcal lung abscesses from a dental focus following tocilizumab: a case report.

de Kruif MD, van Gorp EC, Bel EH, Gerlag DM, Kunst PW.

Clin Exp Rheumatol. 2012 Nov-Dec;30(6):951-3. Epub 2012 Dec 17.

PMID:
23101463
[PubMed - indexed for MEDLINE]
19.

Expression of IL-20 in synovium and lesional skin of patients with psoriatic arthritis: differential response to alefacept treatment.

Lebre MC, Jonckheere CL, Kraan MC, van Kuijk AW, Bos JD, de Rie M, Gerlag DM, Tak PP.

Arthritis Res Ther. 2012 Sep 24;14(5):R200. doi: 10.1186/ar4038.

PMID:
23006144
[PubMed - in process]
Free PMC Article
20.

Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials.

Raza K, Saber TP, Kvien TK, Tak PP, Gerlag DM.

Ann Rheum Dis. 2012 Dec;71(12):1921-3. doi: 10.1136/annrheumdis-2012-201893. Epub 2012 Aug 31.

PMID:
22941769
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk